These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 12801239)

  • 1. SYNOPSIS: SYNthesize and OPtimize System in Silico.
    Vinkers HM; de Jonge MR; Daeyaert FF; Heeres J; Koymans LM; van Lenthe JH; Lewi PJ; Timmerman H; Van Aken K; Janssen PA
    J Med Chem; 2003 Jun; 46(13):2765-73. PubMed ID: 12801239
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LEA3D: a computer-aided ligand design for structure-based drug design.
    Douguet D; Munier-Lehmann H; Labesse G; Pochet S
    J Med Chem; 2005 Apr; 48(7):2457-68. PubMed ID: 15801836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3D-QSAR models on clinically relevant K103N mutant HIV-1 reverse transcriptase obtained from two strategic considerations.
    San Juan AA
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1181-94. PubMed ID: 18155520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revealing interaction mode between HIV-1 reverse transcriptase and diaryltriazine analog inhibitor.
    Li Z; Han J; Chen HF
    Chem Biol Drug Des; 2008 Nov; 72(5):350-9. PubMed ID: 19012571
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Designing active template molecules by combining computational de novo design and human chemist's expertise.
    Lameijer EW; Tromp RA; Spanjersberg RF; Brussee J; Ijzerman AP
    J Med Chem; 2007 Apr; 50(8):1925-32. PubMed ID: 17367122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis, and SAR of a novel pyrazinone series with non-nucleoside HIV-1 reverse transcriptase inhibitory activity.
    Heeres J; de Jonge MR; Koymans LM; Daeyaert FF; Vinkers M; Van Aken KJ; Arnold E; Das K; Kilonda A; Hoornaert GJ; Compernolle F; Cegla M; Azzam RA; Andries K; de Béthune MP; Azijn H; Pauwels R; Lewi PJ; Janssen PA
    J Med Chem; 2005 Mar; 48(6):1910-8. PubMed ID: 15771435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure based activity prediction of HIV-1 reverse transcriptase inhibitors.
    de Jonge MR; Koymans LM; Vinkers HM; Daeyaert FF; Heeres J; Lewi PJ; Janssen PA
    J Med Chem; 2005 Mar; 48(6):2176-83. PubMed ID: 15771460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
    Ranise A; Spallarossa A; Cesarini S; Bondavalli F; Schenone S; Bruno O; Menozzi G; Fossa P; Mosti L; La Colla M; Sanna G; Murreddu M; Collu G; Busonera B; Marongiu ME; Pani A; La Colla P; Loddo R
    J Med Chem; 2005 Jun; 48(11):3858-73. PubMed ID: 15916438
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and evaluation of 2-(2,6-dihalophenyl)-3-pyrimidinyl-1,3-thiazolidin-4-one analogues as anti-HIV-1 agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Bioorg Med Chem; 2007 May; 15(9):3134-42. PubMed ID: 17349793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-(Aryl)-3-furan-2-ylmethyl-thiazolidin-4-ones as selective HIV-RT inhibitors.
    Rawal RK; Prabhakar YS; Katti SB; De Clercq E
    Bioorg Med Chem; 2005 Dec; 13(24):6771-6. PubMed ID: 16198576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. De novo parallel design, synthesis and evaluation of inhibitors against the reverse transcriptase of human immunodeficiency virus type-1 and drug-resistant variants.
    Herschhorn A; Lerman L; Weitman M; Gleenberg IO; Nudelman A; Hizi A
    J Med Chem; 2007 May; 50(10):2370-84. PubMed ID: 17458947
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-HIV activity of HEPT, TIBO, and cyclic urea derivatives: structure-property studies, focused combinatorial library generation, and hits selection using substructural molecular fragments method.
    Solov'ev VP; Varnek A
    J Chem Inf Comput Sci; 2003; 43(5):1703-19. PubMed ID: 14502505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis, anti-HIV activity, and resistance profiles of ribose modified nucleoside phosphonates.
    Mackman RL; Boojamra CG; Prasad V; Zhang L; Lin KY; Petrakovsky O; Babusis D; Chen J; Douglas J; Grant D; Hui HC; Kim CU; Markevitch DY; Vela J; Ray A; Cihlar T
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6785-9. PubMed ID: 18029175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Triazole derivatives as non-nucleoside inhibitors of HIV-1 reverse transcriptase--structure-activity relationships and crystallographic analysis.
    Kirschberg TA; Balakrishnan M; Huang W; Hluhanich R; Kutty N; Liclican AC; McColl DJ; Squires NH; Lansdon EB
    Bioorg Med Chem Lett; 2008 Feb; 18(3):1131-4. PubMed ID: 18083512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The design and synthesis of N-1-alkylated-5-aminoarylalkylsubstituted-6-methyluracils as potential non-nucleoside HIV-1 RT inhibitors.
    Lu X; Chen Y; Guo Y; Liu Z; Shi Y; Xu Y; Wang X; Zhang Z; Liu J
    Bioorg Med Chem; 2007 Dec; 15(23):7399-407. PubMed ID: 17870545
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of 2-(2,6-dibromophenyl)-3-heteroaryl-1,3-thiazolidin-4-ones as anti-HIV agents.
    Rawal RK; Tripathi R; Katti SB; Pannecouque C; De Clercq E
    Eur J Med Chem; 2008 Dec; 43(12):2800-6. PubMed ID: 18242784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of non-nucleoside inhibitors of HIV-1 reverse transcriptase with improved drug resistance properties. 1.
    Hopkins AL; Ren J; Milton J; Hazen RJ; Chan JH; Stuart DI; Stammers DK
    J Med Chem; 2004 Nov; 47(24):5912-22. PubMed ID: 15537346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of structural diversity in combinatorial synthesis.
    Fergus S; Bender A; Spring DR
    Curr Opin Chem Biol; 2005 Jun; 9(3):304-9. PubMed ID: 15939333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Property distributions: differences between drugs, natural products, and molecules from combinatorial chemistry.
    Feher M; Schmidt JM
    J Chem Inf Comput Sci; 2003; 43(1):218-27. PubMed ID: 12546556
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targets looking for drugs: a multistep computational protocol for the development of structure-based pharmacophores and their applications for hit discovery.
    Tintori C; Corradi V; Magnani M; Manetti F; Botta M
    J Chem Inf Model; 2008 Nov; 48(11):2166-79. PubMed ID: 18942779
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.